Minimal Residual Disease (MRD) for Early Detection of Cancer Recurrence (Signatera™, Haystack MRD™)
UDP Glucuronosyltransferase 1A1 (UGT1A1) Genotyping
Hereditary Hemorrhagic Telangiectasia, ENG Gene Mutation Analysis
MLYCD Gene Mutation Analysis, Tissue
Hepatitis D Virus (HDV) Antibody, Total
PDGFRB/TEL Translocation (5;12) for Chronic Myelomonocytic Leukemia, FISH, Blood
Angiotensin Converting Enzyme (ACE), CSF
Paroxetine, Serum
Ethanol (Alcohol), Urine
Aspergillus (Galactomannan) Antigen, Serum
LDS
Sign up
Log in
LDS
/
Medical Tests
/
Minimal Residual Disease (MRD) for Early Detection of Cancer Recurrence (Signatera™, Haystack MRD™)
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
Minimal Residual Disease (MRD) for Early Detection of Cancer Recurrence (Signatera™, Haystack MRD™)
Medical Test
CPT
Access to
Minimal Residual Disease (MRD) for Early Detection of Cancer Recurrence (Signatera™, Haystack MRD™)
is restricted.
Sign up now
Loading...